The involvement of P2Y12 receptors, NADPH oxidase, and lipid rafts in the action of extracellular ATP on synaptic transmission at the frog neuromuscular junction. (29th January 2015)

• Record Type: Journal Article
• Authors: Giniatullin, A.; Petrov, A.; Giniatullin, R.
• Is Part Of: Neuroscience. Volume 285(2015)
• Page Start: 324
• Page End: 332
• Publication Date: 2015-01-29
• Subjects: 2-MeSAMP 2-methylthioadenosine 5′-monophosphate -- ACh acetylcholine -- ATP adenosine 5′-triphosphate -- ADP adenosine 5′-diphosphate -- AEBSF 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride -- CholOx cholesterol oxidase -- DPI diphenyleneiodonium chloride -- EPCs end-plate currents -- MCD methyl-beta-cyclodextrin -- MEPCs miniature end-plate currents -- NOX NADPH oxidase -- ROS reactive oxygen species; neuromuscular junction -- synaptic transmission -- ATP -- P2Y receptor -- NAPDH oxidase -- lipid rafts; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2014.11.039
• Languages: English
• ISSNs: 0306-4522

Abstract

Highlights: Extracellular ATP inhibits synaptic transmission at the frog neuromuscular junction. Inhibition is abolished by the P2Y12 receptor antagonist but not by the P2Y13 one. NADPH oxidase is involved in the inhibitory effect of ATP. Functional state of lipid rafts determines the modulatory effect of ATP. Abstract: Adenosine 5′-triphosphate (ATP) is the main co-transmitter accompanying the release of acetylcholine from motor nerve terminals. Previously, we revealed the direct inhibitory action of extracellular ATP on transmitter release via redox-dependent mechanism. However, the receptor mechanism of ATP action and ATP-induced sources of reactive oxygen sources (ROS) remained not fully understood. In the current study, using microelectrode recordings of synaptic currents from the frog neuromuscular junction, we analyzed the receptor subtype involved in synaptic action of ATP, receptor coupling to NADPH oxidase and potential location of ATP receptors within the lipid rafts. Using subtype-specific antagonists, we found that the P2Y13 blocker 2-[(2-chloro-5-nitrophenyl)azo]-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde did not prevent the depressant action of ATP. In contrast, the P2Y12 antagonist 2-methylthioadenosine 5′-monophosphate abolished the inhibitory action of ATP, suggesting the key role of P2Y12 receptors in ATP action. As the action of ATP is redox-dependent, we also tested potential involvement of the NADPH oxidase, known as a common inducer of ROS. The depressant action of extracellular ATP was significantly reduced by diphenyleneiodonium chloride and 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride, two structurally different inhibitors of NADPH oxidase, indicating that this enzyme indeed mediates the action of ATP. Since the location and activity of various receptors are often associated with lipid rafts, we next tested whether ATP-driven inhibition depends on lipid rafts. We found that the disruption of lipid rafts with methyl-beta-cyclodextrin reduced and largely delayed the action of ATP. Taken together, these data revealed key steps in the purinergic control of synaptic transmission via P2Y12 receptors associated with lipid rafts, and identified NADPH oxidase as the main source of ATP-induced inhibitory ROS at the neuromuscular junction. Our data suggest that the location of P2Y receptors in lipid rafts speeds up the modulatory effect of ATP. Uncovered mechanisms may contribute to motor dysfunctions and neuromuscular diseases associated with oxidative stress.